NHS Health Checks GP Delivery

Award

Buyers

Value

£2,392,810

Suppliers

Classifications

  • Medical practice and related services
  • General-practitioner services
  • Medical specialist services
  • Cardiology services

Tags

  • award
  • contract

Published

4 months ago

Description

This award has been made following the direct award process B of the  The Health Care Services (Provider Selection Regime) Regulations 2023.
This is an existing service, where some providers are existing and some providers are new. All providers who met the requirements were offered contracts (i.e. all main GP Practices within the Local Authorities Boundaries of Milton Keynes City Council, Central Bedfordshire Council and Bedford Borough Council.
The NHS Health Check is a cardiovascular programme aimed at prevention and early identification of cardiovascular conditions. 
The NHS Health Check is made up of three key components: i) risk assessment, ii) risk awareness and iii) risk management. During the risk assessment (i), standardised tests are used to measure key risk factors and establish the individual's risk of developing CVD. The outcome of the assessment is then used to raise awareness of cardiovascular risk factors (ii risk awareness), as well as inform a discussion on, and agreement of, the lifestyle and clinical approaches best suited to managing the individual's health risk (iii risk management). The programme aims to prevent heart disease, stroke, diabetes and kidney disease, and raise awareness of dementia both across the population, in high-risk groups and disadvantaged groups. 
NHS Health Checks are open to individuals aged between 40 and 74 who have not already been diagnosed with one of the conditions listed above.  Eligible individuals will be invited to attend a NHS Health Check once every five years. 
NHS Health Checks are mandatory for all LAs. This service specification relates to the delivery of NHS Health Checks for all patients of GP practices t in Bedford Borough, Central Bedfordshire and Milton Keynes who meet the eligibility criteria stated above. 
Aims and objectives of service:
To reduce the risk of cardiovascular diseases and associated premature deaths in primary care using a proactive approach to identify those at high risk of having a cardiovascular event and increase identification of that risk in line with national best practice guidance.
Lifetime value of contract is estimated to be £2,392,810.00
Contract Dates:
Start Date: 01/04/2025
End Date: 31/03/2030

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

Primary Medical Services at Norwich Health Centre, Beechcroft and Old Palace surgeries, Walk-in-Centre and Inclusion Health Hub in Norwich.

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of NHS Norfolk and Waveney Integrated Care Board (ICB) (The Commissioner) would like to notify the market of an opportunity to provide the following services;<br/><br/>• Lot 1 - General Medical Services under a GMS Contract at Norwich Health Centre (main practice site at Norwich Health Centre and branch sites at Beechcroft Surgery and Old Palace Medical practice).Estimated Annual Contract Value: £1,973,360. Contract Length: this will be a GMS contract held in perpetuity.<br/><br/>• Lot 2 - Alternative Provider Medical Services under an APMS contract at the Walk-in-Centre in Norwich. Estimated Annual Contract Value: £1,844,233. Contract Length: duration of 3 years with the option to extend for up to a further 2 years.<br/><br/>• Lot 3 -Alternative Provider Medical Services under an APMS contract at the Inclusion Health Hub in Norwich. Estimated Annual Contract Value: £453,232. Contract Length: duration of 3 years with the option to extend for up to a further 2 years. <br/><br/>The service commencement dates for all three contracts is 1st April 2026.<br/><br/>Please note the deadline for responses to the Competitive Process is 12:00PM (Mid-day) on 12th September 2025.<br/><br/>Note - the Estimated Total Value in section II.1.5 Estimated total value is based on the annual contract value of all 3 lots due to Lot 1 being in perpetuity.

NHS Norfolk and Waveney Integrated Care Board

NHS Norfolk and Waveney Integrated Care Board

Published 8 hours ago
Open

Occupational Health Physician

Provision of an occupational health physician to provide assessments such as fit-to-work and ill-health retirement For more information about this opportunity, please visit the Delta eSourcing portal at: https://humbersidefire.delta-esourcing.com/tenders/UK-UK-Hull:-Medical-practice-and-related-services./U57CGM37KP To respond to this opportunity, please click here: https://humbersidefire.delta-esourcing.com/respond/U57CGM37KP

Katy Reed

Katy Reed

Published 4 days ago
Open

Batch manufacture of high titer/titre GMP (U.S.A.) compliant lentiviral vector for FDA approval

We are planning a phase I/II clinical trial to treat a rare genetic disease that causes progressive dementia in children. Our therapy will use autologous CD34+ haematopoietic stem progenitor cells (HSPCs) which are modified ex vivo with LVV to express supraphysiologic levels of a secreted enzyme. In order to progress this therapy, we require a high titre LVV produced to good manufacturing practice (GMP) standard. The supplier must have extensive previous experience manufacturing LVVs to this specification which have achieved regulatory approval for phase I/II clinical trials, ideally for use in human CD34+ HSPC transduction. The QC defined must be performed in compliance with FDA regulations. The product of the initial delivery will be delivered directly to the University of California, LA, USA. Note that throughout the document the British spelling ‘Titre’ has been used; this is analogous to the American English term ‘Titer’ and the spellings may be used interchangeably. The University anticipates initially awarding for; - Manufacture of concentrated lentiviral vector (LVV) from a 30L viral harvest - Such award to include any warranties on quality, product replacement (for spoilage), transport, and other supplier project costs such as (but not limited to) quality control testing and audit. The cost estimate of the procurement reflects the anticipated cost of the initial requirement plus contingency, for (for example but not limited to), 1. Scope extension, 2. Additional ad-hoc delivery to support further trials. The time frame of the agreement – 3 years, reflects an initial delivery period expected to be no longer than 12 months post signature, and the option to buy additional deliveries for two years thereafter. The University may award additional deliveries to the awarded supplier via the Negotiated Procedure Without Prior Call for Competition. For transparency we have a budget appetite of approximately USD560k for the delivery of the initial services. We may review this estimate from time to time. Having posted this notice we reserve the right to repost any subsequent notice (including if the ultimate procurement procedure is re-run) under reduced timescales as set out in the regulations.

University Of Edinburgh

University Of Edinburgh

Published 1 week ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

Milton Keynes City Council

Regional or local authority

Procurement Team

[email protected]

Timeline complete

Publish
Bid
Evaluate
Award
Complete